Triamcinolone acetonide (Triamist, Trianaze)
Triamcinolone acetonide
Cipla Medpro (Pty) Ltd
Registration
- Applicant
- Cipla Medpro (Pty) Ltd
- Certificate holder
- Cipla Medpro (Pty) Ltd.
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Triamist EACH METERED SPRAY CONTAINS TRIAMCINOLONE ACETONIDE 55,0 mcg | 55 μgNasal spray | 45067645/21.5.1/0676Approved 31 August 2023 | Registered | Not determined | PIPIL |
| Trianaze EACH METERED SPRAY CONTAINS TRIAMCINOLONE ACETONIDE 55,0 mcg | Not listed | 45067745/21.5.1/0677 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(1S,2S,4R,8S,9S,11S,12R,13S)-12-Fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
Drag to rotate. Structure from PubChem CID 6436.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.